Gamma Delta T Cells and Their Involvement in COVID-19 Virus Infections

被引:33
作者
von Massow, Georg [1 ]
Oh, Steve [2 ]
Lam, Alan [2 ]
Gustafsson, Kenth [1 ]
机构
[1] UCL, Dept Biochem Engn, London, England
[2] ASTAR, Bioproc Technol Inst, Singapore, Singapore
来源
FRONTIERS IN IMMUNOLOGY | 2021年 / 12卷
基金
英国工程与自然科学研究理事会;
关键词
COVID-19; gamma-delta T cell; SARS-Cov-2; lymphopenia; T cells; ACUTE RESPIRATORY SYNDROME; PROFESSIONAL ANTIGEN-PRESENTATION; PERIPHERAL-BLOOD; IMMUNE-RESPONSES; ZOLEDRONIC ACID; CYSTIC-FIBROSIS; CYTOKINE STORM; IN-VITRO; LYMPHOCYTES; IMMUNOTHERAPY;
D O I
10.3389/fimmu.2021.741218
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The global outbreak of the SARS-Cov-2 virus in 2020 has killed millions of people worldwide and forced large parts of the world into lockdowns. While multiple vaccine programs are starting to immunize the global population, there is no direct cure for COVID-19, the disease caused by the SARS-Cov-2 infection. A common symptom in patients is a decrease in T cells, called lymphopenia. It is as of yet unclear what the exact role of T cells are in the immune response to COVID-19. The research so far has mainly focused on the involvement of classical alpha beta T cells. However, another subset of T cells called gamma delta T cells could have an important role to play. As part of the innate immune system, gamma delta T cells respond to inflammation and stressed or infected cells. The gamma delta T cell subset appears to be particularly affected by lymphopenia in COVID-19 patients and commonly express activation and exhaustion markers. Particularly in children, this subset of T cells seems to be most affected. This is interesting and relevant because gamma delta T cells are more prominent and active in early life. Their specific involvement in this group of patients could indicate a significant role for gamma delta T cells in this disease. Furthermore, they seem to be involved in other viral infections and were able to kill SARS infected cells in vitro. gamma delta T cells can take up, process and present antigens from microbes and human cells. As e.g. tumour-associated antigens are presented by MHC on gamma delta T cells to classical T-cells, we argue here that it stands to reason that also viral antigens, such as SARS-Cov-2-derived peptides, can be presented in the same way. gamma delta T cells are already used for medical purposes in oncology and have potential in cancer therapy. As gamma delta T cells are not necessarily able to distinguish between a transformed and a virally infected cell it could therefore be of great interest to investigate further the relationship between COVID-19 and gamma delta T cells.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines
    Biswajit Biswas
    Shagnik Chattopadhyay
    Sayantee Hazra
    Arman Kunwar Hansda
    Ritobrata Goswami
    Inflammation Research, 2022, 71 : 377 - 396
  • [42] COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines
    Biswas, Biswajit
    Chattopadhyay, Shagnik
    Hazra, Sayantee
    Hansda, Arman Kunwar
    Goswami, Ritobrata
    INFLAMMATION RESEARCH, 2022, 71 (04) : 377 - 396
  • [43] Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19
    José Lucas Martins Rocha
    Waldir César Ferreira de Oliveira
    Nádia Cássia Noronha
    Natalia Cristine Dias dos Santos
    Dimas Tadeu Covas
    Virgínia Picanço-Castro
    Kamilla Swiech
    Kelen Cristina Ribeiro Malmegrim
    Stem Cell Reviews and Reports, 2021, 17 : 71 - 93
  • [44] Recognition by gamma/delta T cells
    Chien, YH
    Jores, R
    Crowley, MP
    ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 511 - 532
  • [45] Gamma/delta T cells as cellular vehicles for anti-tumor immunity
    Wang, Chelsia Qiuxia
    Lim, Pei Yu
    Tan, Andy Hee-Meng
    FRONTIERS IN IMMUNOLOGY, 2024, 14
  • [46] Memory T Cells Discrepancies in COVID-19 Patients
    Al Saihati, Hajir A.
    Hussein, Hosni A. M.
    Thabet, Ali A.
    Wardany, Ahmed A.
    Mahmoud, Sabry Y.
    Farrag, Eman S.
    Mohamed, Taha I. A.
    Fathy, Samah M.
    Elnosary, Mohamed E.
    Sobhy, Ali
    Ahmed, Abdelazeem E.
    El-Adly, Ahmed M.
    El-Shenawy, Fareed S.
    Elsadek, Asmaa A.
    Rayan, Amal
    Zahran, Zeinab Albadry M.
    El-Badawy, Omnia
    El-Naggar, Mohamed G. M.
    Afifi, Magdy M.
    Zahran, Asmaa M.
    MICROORGANISMS, 2023, 11 (11)
  • [47] Mucosal-Associated Invariant T Cells as a Possible Target to Suppress Secondary Infections at COVID-19
    Akasov, Roman A.
    Khaydukov, Evgeny V.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [48] The phenotypic changes of γδ T cells in COVID-19 patients
    Lei, Lei
    Qian, Hongbo
    Yang, Xiaofang
    Zhang, Xingzhe
    Zhang, Dan
    Dai, Tongxin
    Guo, Rui
    Shi, Lin
    Cheng, Yanbin
    Zhang, Baojun
    Zhou, Xiaobo
    Hu, Jinsong
    Guo, Yaling
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (19) : 11603 - 11606
  • [49] Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients
    Gozzi-Silva, Sarah Cristina
    Oliveira, Luana de Mendonca
    Alberca, Ricardo Wesley
    Pereira, Natalli Zanete
    Yoshikawa, Fabio Seiti
    Pietrobon, Anna Julia
    Yendo, Tatiana Mina
    de Souza Andrade, Milena Mary
    Leuzzi Ramos, Yasmim Alefe
    Brito, Cyro Alves
    Oliveira, Emily Araujo
    Beserra, Danielle Rosa
    Orfali, Raquel Leao
    Aoki, Valeria
    da Silva Duarte, Alberto Jose
    Sato, Maria Notomi
    CELLS, 2022, 11 (21)
  • [50] The Unrecognized Threat of Secondary Bacterial Infections with COVID-19
    Vaillancourt, Mylene
    Jorth, Peter
    MBIO, 2020, 11 (04): : 1 - 3